Black Friday Sale
Black Friday Sale
HomeNewscoronavirusIndia develops herd immunity; BF.7 variant may not be as serious as in China: CCMB chief

India develops herd immunity; BF.7 variant may not be as serious as in China: CCMB chief

Maintaining that at this point it cannot be asserted that there may or may not be a wave in India, Nandicoori said as of now it does not seem to be that alarming that a wave is coming right away.

December 25, 2022 / 11:46 IST
Representative Image (Image: Reuters)

The severity of BF.7 variant of coronavirus in India may not be as serious as it is currently prevailing in China as Indian have already developed "herd immunity" a top official of CSIR- Centre for Cellular and Molecular Biology (CCMB) here said.

Vinay K Nandicoori, Director CCMB, stressing the need to follow Covid appropriate behaviour, said there is always a concern that all these variants have the ability to escape the immunity and can infect people who are vaccinated and even sometimes infected with the previous variants of Omicron.

"The severity of the infection is not as much as they used to be with Delta. That's because of the fact that we do have herd immunity to an extent. Actually we have herd immunity because we are exposed to the other viruses," he told PTI.

Media reports indicate that India reported four cases of BF.7 variant of coronavirus.

"We (India) have seen the Delta wave which is a big one. Then we have got vaccination done. And then the Omicron wave came and we continued booster doses. We are different in many ways. What is happening in China may not happen in India because of that," he further said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India reported 201 new coronavirus infections, while the active cases increased to 3,397, the Union health Ministry said on Saturday.

The official said the "Zero Covid Policy" followed by China is one of the reasons for the outbreak of the infection in that country and opined that lower vaccination levels may also have contributed to the severity.

"It is actually that (the zero Covid policy that China is followed) and also the fact is in China, not many people really went for the vaccine as it has happened in India all the older population is vaccinated and sometimes even sometimes booster dose has been given to older population or susceptible population," he said.

Maintaining that at this point it cannot be asserted that there may or may not be a wave in India, Nandicoori said as of now it does not seem to be that alarming that a wave is coming right away.

Currently there is enough capacity within India both for the Covid tests as well as therapy and vaccination. They are accessible to many people, he added.

PTI
first published: Dec 25, 2022 11:46 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347